Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—The purpose of this study was to test the hypothesis that any degree of abnormal glucose homeostasis detected on antepartum screening for gestational diabetes mellitus (GDM) should be associated with an increased risk of postpartum pre-diabetes or diabetes. RESEARCH DESIGN AND METHODS—In this prospective cohort study, 487 women underwent 1) antepartum GDM screening by a glucose challenge test (GCT) and a diagnostic oral glucose tolerance test (OGTT) and 2) postpartum metabolic characterization by OGTT at 3 months after delivery. Four baseline glucose tolerance groups were defined on the basis of the antepartum GCT/OGTT: 1) GDM (n = 137); 2) gestational impaired glucose tolerance (GIGT) (n = 91); 3) abnormal GCT with normal glucose tolerance on an OGTT (abnormal GCT NGT) (n = 166); and 4) normal GCT with NGT on an OGTT (normal GCT NGT) (n = 93). RESULTS—The prevalence of postpartum glucose intolerance (pre-diabetes or diabetes) increased across the groups from normal GCT NGT (3.2%) to abnormal GCT NGT (10.2%) to GIGT (16.5%) to GDM (32.8%) (Ptrend < 0.0001). On logistic regression analysis, all three categories of abnormal glucose homeostasis in pregnancy independently predicted postpartum glucose intolerance: abnormal GCT NGT odds ratio (OR) 3.6 (95% CI 1.01–12.9); GIGT OR 5.7 (1.6–21.1); and GDM OR 14.3 (4.2–49.1). Furthermore, both in pregnancy and at 3 months postpartum, insulin sensitivity (ISOGTT) and pancreatic β-cell function (insulinogenic index/homeostasis model assessment of insulin resistance) progressively decreased across the groups from normal GCT NGT to abnormal GCT NGT to GIGT to GDM (all Ptrend < 0.0001). CONCLUSIONS—Any degree of abnormal glucose homeostasis in pregnancy independently predicts an increased risk of glucose intolerance postpartum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Self-citationThe Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
Increasing Incidence of Diabetes After Gestational Diabetes
Lauenborg, J., Hansen, T., Jensen, D. M., Vestergaard, H., Mølsted-Pedersen, L., Hornnes, P., Locht, H., Pedersen, O., & Damm, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1194 · Cited by 257
Predictors of postpartum diabetes in women with gestational diabetes mellitus
Löbner, K., Knopff, A., Baumgarten, A., Mollenhauer, U., Marienfeld, S., Garrido-Franco, M., Bonifacio, E., & Ziegler, A.-G. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0746 · Cited by 234
Maternal and Fetal Outcomes if Gestational Impaired Glucose Tolerance Is Not Treated
Östlund, I., Hanson, U., Björklund, A., Hjertberg, R., Eva, N., Nordlander, E., Marja-Liisa, S., & Wager, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2107 · Cited by 151 · cited 1×
“carry an enhanced risk of adverse obstetrical outcomes (22-27).”
Background
Cited by
Retnakaran, R., & Shah, B. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090569 · Cited by 194
Self-citationGlucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Zinman, B., & Hanley, A. J. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1990 · Cited by 190
Self-citationRetnakaran, R., & Shah, B. R. (2017) · Diabetes Care · doi:10.2337/dc16-1400 · Cited by 167
“As the incidence of impaired glucose tolerance (IGT) is known to be much higher in womenwith previous GDM than in their peers (8,21), it is possible that the po-”
BackgroundSelf-citationRosario, F. J., Kanai, Y., Powell, T. L., & Jansson, T. (2015) · Obesity · doi:10.1002/oby.21165 · Cited by 128
“, not just GDM) independently predicts glucose intolerance in the postpartum period (28).”
Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
Moon, J. H., Kwak, S. H., & Jang, H. C. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.203 · Cited by 93
Metadata
- Authors
- Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J. G., & Zinman, B.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 31
- Issue
- 10
- Pages
- 2026-2031
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2100830205
- Cited by
- 251
- References
- 12
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.